Milestone Scientific, Inc. (MLSS): Price and Financial Metrics
MLSS Stock Summary
- With a one year PEG ratio of 915.42, Milestone Scientific Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.38% of US stocks.
- MLSS's price/sales ratio is 30.36; that's higher than the P/S ratio of 92.45% of US stocks.
- With a year-over-year growth in debt of 5,799.7%, Milestone Scientific Inc's debt growth rate surpasses 99.54% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Milestone Scientific Inc, a group of peers worth examining would be DGLY, AMSF, RIBT, NWPX, and WLDN.
- Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.
MLSS Stock Price Chart Interactive Chart >
MLSS Price/Volume Stats
| Current price | $2.51 | 52-week high | $4.85 |
| Prev. close | $2.47 | 52-week low | $1.30 |
| Day low | $2.40 | Volume | 183,186 |
| Day high | $2.52 | Avg. volume | 731,110 |
| 50-day MA | $3.60 | Dividend yield | N/A |
| 200-day MA | $2.35 | Market Cap | 167.06M |
Milestone Scientific, Inc. (MLSS) Company Bio
Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.
Latest MLSS News From Around the Web
Below are the latest news stories about Milestone Scientific Inc that investors may wish to consider to help them evaluate MLSS as an investment opportunity.
Milestone Scientific's (MLSS) CEO Leonard Osser on Q4 2020 Results - Earnings Call TranscriptMilestone Scientific, Inc. (MLSS) Q4 2020 Earnings Conference Call April 1, 2021 4:30 PM ET Company Participants Natalya Rudman – Senior Vice President and Director of Market Intelligence-Crescendo Communications, LLC Leonard Osser – Interim Chief Executive Officer Arjan Haverhals – President-Milestone Scientific and Chief Executive Officer-Wand Dental Joseph D’Agostino –... |
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural SystemROSELAND, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the full year ending December 31, 2020. Arjan Haverhals, President of Milestone Scientific and CEO of Wand Dental Inc., stated, "I am pleased to report that our revenue for the fourth quarter of 2020 increased sequentially by approximately $1 million, or 78% versus the third quarter of 2020. Importantly, we carefully managed our operating expenses during the year and reduced our net loss. We achieved these strong results despite... |
Milestone Scientific Schedules 2020 Year-End Business Update Conference CallROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 4:30 p.m. Eastern Time on Thursday, April 1, 2021 to discuss the Company’s financial results for the full year ending December 31, 2020, as well as the Company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 1- 877-407-0778 for U.S. callers or 201-689-8565 for international callers. A webcast of the call may be accessed here or on the Company’s website at https://www.milestonescientific.com/. An audio replay of the of the call will be available through A... |
Milestone Scientific, Inc. (MLSS) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseMilestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South CarolinaROSELAND, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it has begun selling CompuFlo® / CathCheck™ disposables to the Medical University of South Carolina (MUSC). The MUSC University Medical Center is a nationally recognized and leading health sciences university, recently ranked as the number one hospital in South Carolina. MUSC Health owns and operates eight hospitals and provides patient care throughout the state of South Carolina. Arjan Haverhals, President of Milestone Scientific, further noted, “We appreciate the support of Dr. Hebbar, Director Obstetrics Anesthesia, and her team at MUSC. This latest comm... |
MLSS Price Returns
| 1-mo | -26.82% |
| 3-mo | -14.92% |
| 6-mo | 41.81% |
| 1-year | 57.86% |
| 3-year | 217.72% |
| 5-year | 32.11% |
| YTD | 18.40% |
| 2020 | 52.52% |
| 2019 | 318.67% |
| 2018 | -71.86% |
| 2017 | -15.71% |
| 2016 | -40.43% |
Continue Researching MLSS
Want to do more research on Milestone Scientific Inc's stock and its price? Try the links below:Milestone Scientific Inc (MLSS) Stock Price | Nasdaq
Milestone Scientific Inc (MLSS) Stock Quote, History and News - Yahoo Finance
Milestone Scientific Inc (MLSS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...